Vaughan Nelson Investment Management L.P. Sells 12,365 Shares of Axon Enterprise, Inc $AXON

Vaughan Nelson Investment Management L.P. lowered its holdings in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 22.5% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 42,642 shares of the biotechnology company’s stock after selling 12,365 shares during the period. Vaughan Nelson Investment Management L.P.’s holdings in Axon Enterprise were worth $24,218,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of the business. Stone House Investment Management LLC acquired a new position in shares of Axon Enterprise in the 3rd quarter valued at $29,000. New Millennium Group LLC acquired a new stake in shares of Axon Enterprise during the 3rd quarter valued at about $29,000. Root Financial Partners LLC bought a new stake in Axon Enterprise in the third quarter valued at about $34,000. Darwin Wealth Management LLC bought a new stake in Axon Enterprise in the second quarter valued at about $37,000. Finally, Elevation Point Wealth Partners LLC acquired a new position in Axon Enterprise in the second quarter worth about $56,000. Institutional investors own 79.08% of the company’s stock.

Insider Buying and Selling at Axon Enterprise

In other news, Director Erika Nardini sold 198 shares of the stock in a transaction on Tuesday, March 17th. The stock was sold at an average price of $506.58, for a total value of $100,302.84. Following the transaction, the director owned 1,946 shares of the company’s stock, valued at $985,804.68. This represents a 9.24% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, insider Isaiah Fields sold 2,000 shares of the firm’s stock in a transaction dated Friday, February 27th. The stock was sold at an average price of $535.01, for a total value of $1,070,020.00. Following the transaction, the insider owned 55,588 shares in the company, valued at approximately $29,740,135.88. This trade represents a 3.47% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 23,855 shares of company stock valued at $13,299,928 over the last 90 days. Company insiders own 5.70% of the company’s stock.

Wall Street Analyst Weigh In

AXON has been the subject of a number of analyst reports. UBS Group cut their price target on shares of Axon Enterprise from $610.00 to $570.00 and set a “neutral” rating for the company in a research note on Wednesday, February 25th. Piper Sandler dropped their target price on Axon Enterprise from $753.00 to $690.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Craig Hallum restated a “buy” rating and set a $820.00 target price on shares of Axon Enterprise in a research report on Wednesday, February 25th. Northcoast Research raised Axon Enterprise from a “neutral” rating to a “buy” rating and set a $742.00 price target on the stock in a research note on Tuesday, January 6th. Finally, Needham & Company LLC dropped their price objective on Axon Enterprise from $870.00 to $600.00 and set a “buy” rating for the company in a research note on Friday, February 20th. Sixteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $762.93.

Axon Enterprise Stock Performance

NASDAQ:AXON opened at $424.69 on Wednesday. The stock has a market capitalization of $34.15 billion, a P/E ratio of 279.40, a price-to-earnings-growth ratio of 8.86 and a beta of 1.46. The company has a current ratio of 2.53, a quick ratio of 2.29 and a debt-to-equity ratio of 0.53. Axon Enterprise, Inc has a 1 year low of $396.41 and a 1 year high of $885.91. The firm has a 50 day moving average of $493.71 and a 200-day moving average of $585.07.

Axon Enterprise (NASDAQ:AXON) last released its quarterly earnings results on Tuesday, February 24th. The biotechnology company reported $2.15 earnings per share for the quarter, beating analysts’ consensus estimates of $1.60 by $0.55. The firm had revenue of $796.72 million during the quarter, compared to analysts’ expectations of $755.29 million. Axon Enterprise had a return on equity of 2.82% and a net margin of 4.48%.The business’s revenue was up 38.5% on a year-over-year basis. During the same period last year, the firm posted $2.08 EPS. As a group, sell-side analysts anticipate that Axon Enterprise, Inc will post 5.8 EPS for the current fiscal year.

About Axon Enterprise

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.